ClinicaliQ Trial Snapshot
- Post-Market Study to Assess iTind Safety in Comparison to UroLift — Recruiting • Non-phase study • NCT04757116.
- iTind and UroLift devices show similar safety and effectiveness for treating enlarged prostate symptoms in men.
Verify eligibility, endpoints and current status on the original ClinicalTrials.gov registry before acting on this summary.
Use This Page For
- Quick orientation before opening the registry record.
- Checking recruitment status, phase and sponsor at a glance.
- Connecting this trial to nearby guidelines, Drug Science and education.
What This Trial Is Studying
The study objective is to evaluate the efficacy and safety of the iTind device compared to UroLift. Conditions: Benign Prostatic Hyperplasia (BPH) Interventions: iTind, UroLift Lead Sponsor: Olympus Corporation of the Americas Planned Enrollment: 256 participants